Pre Next

PDF Download

[1] ZHANGJunru,.TreatmentofChronicHeartFailurewithHyperuricemiafromthePerspectiveofTraditionalChineseandWesternMedicine [J]. Modern Traditional Chinese Medicine, 2021, (03): 1-5. [doi: 10.13424/j.cnki.mtcm.2021.03.001]

Copy

TreatmentofChronicHeartFailurewithHyperuricemiafromthePerspectiveofTraditionalChineseandWesternMedicine

Modern Traditional Chinese Medicine[ISSN: 1006-6977/ CN: 61-1281/TN] Volumes & Issues: 2021 03 pagination: 1-5 Column: Publication date: 2021-05-20

Article number:: 1672-0571(2021)03-0001-05

Author(s):: ZHANGJunru¹; 2; PreventiveTreatmentCenter,XiyuanHospital,ChinaAcademyofChineseMedicalSciences,Beijing100091,China

Keywords:: Chronicheartfailure; Hyperuricemia; IntegratedtraditionalChineseandWesternmedicinetreatment

ZTFLH:: R541.6

DOI:: 10.13424/j.cnki.mtcm.2021.03.001

Code:: A

Abstract:: Chronicheartfailure(CHF)andhyperuricemia(HUA)arecloselyrelatedandinteractwitheachother,whichhasimportantclinicalsignificance.Onthebasisofliteraturereview,thispapersystematicallyanalyzedtheclinicalsignificance,diagnosisandtreatmentstatusandexistingproblemsofintegratedtraditionalChineseandWesternmedicineinthetreatmentofchronicheartfailurewithhyperuricemia,andemphaticallydiscussedthepathologicalmechanism,treatmentprinciple,representativecompoundandtreatmentprospectofchronicheartfailureandhyperuricemiafromtheperspectiveoftraditionalChinesemedicine

References:

[1]JHUNDPS,MacintyreK,SimpsonCR,etal.Longtermtrendsinfirsthospitalizationforheartfailureandsubsequentsurvivalbetween1986and2003:Apopulationstudyof5.1millionpeople[J].Circulation,2009,(119):515-523.
[2]BorqhiC,CosentinoER,RinaldiER,etal.Uricaemiaandejectionfractioninelderlyheartfailureoutpatients[J].EurJClinInvest,2014,44(6):573-578.
[3]PalazzuoliA,RuoccoC,PellegriniM,etal.Prognosticsignificanceofhyperuricemiainpatientswithacuteheartfailure[J].AmJCardiol,2016,117(10):1616-1621.
[4]SakaiH,TsutamotoT,TsutsuiT,etal.Serumlevelofuricacid,partlysecretedfromthefailingheart,isaprognosticmarkerinpatientswithcongestiveheartfailure[J].CircJ,2006,(70):1006-1011.
[5]叶丁容,黄娉欢,李月琼,等.血清尿酸水平与充血性心力衰竭严重程度的相关性分析 [J].中外医疗,2020,(19):76-78.
[6]杨敏,陈广玲,吴贤仁,等.心力衰竭患者血清尿酸水平的变化[J].中国心血管病研究杂志,2006,4(4):257-259.
[7]王传合,于彤彤,董媛媛,等.高尿酸血症与慢性心力衰竭的相关性分析[J].中国动脉硬化杂志,2015,23(10):1043-1047.
[8]高芳芳,王世一,杨倩文,等.高尿酸血症对不同射血分数心力衰竭的影响[J].中国心血管杂志,2019,24(5):490-492.
[9]BoveM,CiceroAF,VeronesiM,etal.Anevidence-basedreviewonurate-loweringtreatments:implicationsforoptimaltreatmentofchronichyperuricemia[J].VascHealthRiskManag,2017,(13):23-28.
[10]何青,唐国栋.高尿酸血症与冠心病[J].中国心血管杂志,2016,21(1):1-4.
[11]HuangH,HuangB,LiY,etal.Uricacidandriskofheartfailure:asystematicreviewandmeta-analysis[J].EurJHeartFail,2014,(16):15-24
[12]ChenJH,ChuangSY,ChenHJ,etal.Serumuricacidlevelasanindependentriskfactorforallcause,cardiovascular,andischemicstrokemortality:aChinesecohortstudy[J].ArthritisRheum,2009,(61):225e32.
[13]AminA,VakilianF,MalekiM.Serumuricacidlevelscorrelatewithfillingpressuresinsystolicheartfailure:fillingpressuresinsystolicheartfailure[J].CongestHeartFail,2011,(17):79-83.
[14]单瑞,程爱娟,吴尚勤,等.苯溴马隆与别嘌醇对心力衰竭伴高尿酸血症患者炎症因子及心功能的影响[J].中华高血压杂志,2014,4(22):380382.
[15]张倩,杨星林.非布司他对伴高尿酸血症的老年慢性心力衰竭患者心功能的影响[J].中国心血管杂志,2018,23(6):468-469.
[16]HareJM,MangalB,BrownJ,eta1.Impactofoxypurinolinpatientswithsymptomaticheartfailure.ResultsoftheOPTCHFstudy[J].JAmCollCardiol,2008,(51):2301-2309.
[17]GivertzMM,AnstromKJ,RedfifieldMM,eta1.Effectsofxanthineoxidaseinhibitioninhyperuricemicheartfailurepatients:theXanthineOxidaseInhibitionforHyperuricemicHeartFailurePatients(EXACT-HF)study[J].Circulation,2015,(131):1763-71.
[18]WhiteWB,SaagKG,BeckerMA,eta1.Cardiovascularsafetyoffebuxostatorallopurinolinpatientswithgout[J].NEngJMed,2018,378(13):1200-1210.
[19]孔晓艳,鲁一兵.GLT2抑制剂对 2型糖尿病患者血尿酸水平的影响[J].国际内分泌代谢杂志,2020,(2):97-99.
[20]InzucchiSE,ZinmanB,FitchettD,etal.Howdoesempagliflflozinreducecardiovascularmortality?InsightsfromamediationanalysisoftheEMPA-REGOUTCOMEtrial[J].DiabetesCare,2018,(41):35663.
[21]LiJW,WoodwardM,PerkovicV,etal.Mediatorsoftheeffectsofcanagli-flflozinonheartfailureinpatientswithtype2diabetes[J].JACCHeartFail,2020,(8):57-66.
[22]VERMAS,JIQH,BHATTDL,etal.Associationbetweenuricacidlevelsandcardio-renaloutcomesanddeathinpatientswithtype2diabetes:asubanalysisofEMPA-REGOUTCOME[J].DiabetesObesMetab,2020,22(7):1207-1214.
[23]KosiborodMN,JhundPS,DochertyKF,etal.Effectsofdapagliflozinonsymptoms,function,andqualityoflifeinpatientswithheartfailureandreducedejectionfraction:ResultsfromtheDAPA-HFtrail[J].Circulation,2020,141(2):90-99.
[24]MartinezFA,SerenelliM,NicolauJC,etal.Efficacyandsafetyofdapagliflozininheartfailurewithreducedejectionfractionaccordingtoage:insightsFrom DAPA-HF[J].Circulation,2020,141(2):100111.
[25]刘风琴.化湿降浊方干预慢性心力衰竭伴高尿酸血症患者临床研究[D].黄芪南京中医药大学,2016.
[26]唐群.益气活血利水法治疗气虚血瘀型慢性心力衰竭合并高尿酸血症的疗效[J].医学信息,2020,33(12):152-154.
[27]孙晓妮.中医方药配合抗心衰药物治疗慢性心力衰竭伴高尿酸血症的疗效分析[J].内蒙古中医药,2020,39,(5):25-26.
[28]严容,彭吉新,徐佳杨,等.中西医结合治疗慢性心力衰竭合并高尿酸血症 40例总结[J].湖南中医杂志,2020,36(10):25-28.
[29]张阳阳,郑刚,任耀龙,等.慢性心力衰竭合并高尿酸血症患者的中医证素分布规律研究[J].中国中医急症,2020,29(6):974-976.
[30]张军茹.从心肾同病?阴阳互根角度看慢性充血性心力衰竭的防治[J].医学信息,2011,24(12):730-731.
[31]张军茹,张冠杰.“阳化气?阴成形”理论及其在心衰治疗中应用价值探讨[J].中医药临床杂志,2014,26(4):336-337.
[32]张军茹,任得志.养心合剂治疗慢性心力衰竭临床观察[J].陕西中医,2015,36(2):143-144.
[33]张军茹.基于津气并调论慢性心衰的容量管理[J].陕西中医药大学学报,2020,43(1):34-36,53.
[34]刘风琴,顾宁.慢性心力衰竭合并高尿酸血症的中西医研究进展[J].现代中西医结合杂志,2016,25(13):1480-1482.
[35]孙晓妮.中医方药配合抗心衰药物治疗慢性心力衰竭伴高尿酸血症的疗效分析[J].内蒙古中医药,2020,39(05):25-26.
[36]杨明月.益心定悸方Ⅱ号治疗慢性心力衰竭(气虚血瘀型)伴高尿酸血症临床疗效观察[D].哈尔滨:黑龙江中医药大学,2019.
[37]李立荣.四妙丸加减配合耳穴压豆治疗慢性心力衰竭合并高尿酸血症的临床观察[J].中医临床研究,2019,11(20):34-36.

Memo

基金项目：第四批全国优秀临床人才项目（国中药人教发［２０１７］２４号）

Last Update: 2021-06-08